@article{49000,
      author = {Faraz Kermani, Scrip,},
      url = {http://tind.wipo.int/record/49000},
      title = {Not all pharma IP law is transferable.},
      abstract = {The battle for supremacy between Europe and the US in the  fields of pharmaceutical R&D and innovation has pointlessly  flared up once again. A recently published survey by  international intellectual property specialists Marks &  Clerk indicates that the US IP system is viewed as being  more favourable to innovation and that President Obama's  recently passed healthcare reforms are proving to be  increasingly palatable for big pharma.},
      recid = {49000},
      pages = {GB 139 May 2010 ;},
}